Regents of the University of California’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-13,928
| Closed | -$768K | – | 33 |
|
|
2020
Q3 | $768K | Hold |
13,928
| – | – | 0.11% | 19 |
|
|
2020
Q2 | $879K | Hold |
13,928
| – | – | 0.12% | 18 |
|
|
2020
Q1 | $712K | Hold |
13,928
| – | – | 0.11% | 18 |
|
|
2019
Q4 | $1.11M | Hold |
13,928
| – | – | 0.58% | 15 |
|
|
2019
Q3 | $676K | Hold |
13,928
| – | – | 1.29% | 20 |
|
|
2019
Q2 | $733K | Hold |
13,928
| – | – | 2.07% | 17 |
|
|
2019
Q1 | $673K | Hold |
13,928
| – | – | 1.58% | 16 |
|
|
2018
Q4 | $572K | Hold |
13,928
| – | – | 1.38% | 19 |
|
|
2018
Q3 | $529K | Hold |
13,928
| – | – | 1.03% | 19 |
|
|
2018
Q2 | $630K | Hold |
13,928
| – | – | 1.65% | 15 |
|
|
2018
Q1 | $673K | Hold |
13,928
| – | – | 1.23% | 16 |
|
|
2017
Q4 | $548K | Buy |
+13,928
| New | +$548K | 0.83% | 22 |
|